Development of antisense therapeutics. Implications for cancer gene therapy.
Gilead Sciences, Foster City, California 94404.
J F
JF
Milligan
R J
RJ
Jones
B C
BC
Froehler
M D
MD
Matteucci
D000818:Animals; D017209:Apoptosis; D001483:Base Sequence; D002455:Cell Division; D002463:Cell Membrane Permeability; D016373:DNA, Antisense / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D008969:Molecular Sequence Data; D009857:Oncogenes; D051381:Rats; D013329:Structure-Activity Relationship
D016373:DNA, Antisense